共 41 条
Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type
被引:54
作者:
Ueyama, Hiroya
[1
]
Yao, Takashi
[2
]
Akazawa, Yoichi
[1
]
Hayashi, Takuo
[3
]
Kurahara, Koichi
[4
]
Oshiro, Yumi
[5
]
Yamada, Masaoshi
[6
]
Oda, Ichiro
[6
]
Fujioka, Shin
[7
]
Kusumoto, Chiaki
[8
]
Fukuda, Masayoshi
[9
]
Uchita, Kunihisa
[10
]
Kadota, Tomohiro
[11
]
Oono, Yasuhiro
[11
]
Okamoto, Kazuhisa
[12
]
Murakami, Kazunri
[12
]
Matsuo, Yasumasa
[13
]
Kato, Motohiko
[14
,15
]
Maehata, Tadateru
[15
]
Yahagi, Naohisa
[15
]
Yasuhara, Yumiko
[16
]
Yada, Tomoyuki
[17
]
Uraushihara, Koji
[18
]
Yamane, Tetumi
[19
]
Matsuo, Taiji
[20
]
Ito, Masanori
[21
]
Maruyama, Yasuhiko
[22
]
Osako, Ayumi
[23
]
Ono, Shoko
[24
]
Kato, Mototsugu
[25
]
Yagi, Kazuyoshi
[26
]
Hashimoto, Takashi
[27
]
Tomita, Natsumi
[27
]
Tsuyama, Sho
[3
]
Saito, Tsuyoshi
[3
]
Matsumoto, Kohii
[1
]
Matsumoto, Kenshi
[1
]
Watanabe, Sumio
[1
]
Uemura, Naomi
[17
]
Chiba, Tsutomu
[28
,29
]
Nagahara, Akihiito
[1
]
机构:
[1] Juntendo Univ, Dept Gastroenterol, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[2] Juntendo Univ, Dept Human Pathol, Grad Sch Med, Tokyo, Japan
[3] Juntendo Univ, Dept Human Pathol, Sch Med, Tokyo, Japan
[4] Matsuyama Red Cross Hosp, Dept Gastroenterol, Matsuyama, Ehime, Japan
[5] Matsuyama Red Cross Hosp, Dept Pathol, Matsuyama, Ehime, Japan
[6] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan
[7] Fukuoka Red Cross Hosp, Div Gastroenterol, Fukuoka, Japan
[8] Nippon Kokan Fukuyama Hosp, Dept Gastroenterol, Hiroshima, Japan
[9] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan
[10] Kochi Red Cross Hosp, Dept Gastroenterol, Kochi, Japan
[11] Natl Canc Ctr Hosp East, Dept Gastroenterol & Endoscopy, Chiba, Japan
[12] Oita Univ, Fac Med, Dept Gastroenterol, Oita, Japan
[13] St Marianna Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Kawasaki, Kanagawa, Japan
[14] Keio Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan
[15] Keio Univ, Canc Ctr, Div Res & Dev Minimally Invas Treatment, Sch Med, Tokyo, Japan
[16] Kyoto Katsura Hosp, Dept Diagnost Pathol, Kyoto, Japan
[17] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan
[18] Showa Gen Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
[19] Tottori Red Cross Hosp, Dept Diagnost Pathol, Tottori, Japan
[20] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan
[21] Hiroshima Univ Hosp, Dept Gen Internal Med, Hiroshima, Japan
[22] Fujieda Municipal Gen Hosp, Dept Gastroenterol, Shizuoka, Japan
[23] Tottori Seikyo Hosp, Dept Gastroenterol, Tottori, Japan
[24] Hokkaido Univ Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan
[25] Hakodate Natl Hosp, Dept Gastroenterol, Natl Hosp Org, Hakodate, Hokkaido, Japan
[26] Niigata Univ Med & Dent Hosp, Uonuma Inst Community Med, Dept Gastroenterol & Hepatol, Niigata, Japan
[27] Juntendo Univ, Dept Esophageal & Gastroenterol Surg, Sch Med, Tokyo, Japan
[28] Kyoto Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Kyoto, Japan
[29] Kansai Elect Power Hosp, Osaka, Japan
关键词:
Gastric adenocarcinoma of fundic-gland type;
Gastric adenocarcinoma of fundic-gland mucosa type;
Gastric epithelial neoplasm of fundic-gland mucosa lineage;
Oxyntic gland adenoma;
CATENIN SIGNALING PATHWAY;
WELL-DIFFERENTIATED ADENOCARCINOMA;
STOMACH;
MUTATION;
ADENOMA;
GNAS;
D O I:
10.1007/s00535-021-01813-z
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Background Gastric adenocarcinoma of fundic-gland type (GA-FG) is a rare variant of gastric neoplasia. However, the etiology, classification, and clinicopathological features of gastric epithelial neoplasm of fundic-gland mucosa lineage (GEN-FGML; generic term of GA-FG related neoplasm) are not fully elucidated. We performed a large, multicenter, retrospective study to establish a new classification and clarify the clinicopathological features of GEN-FGML. Methods One hundred GEN-FGML lesions in 94 patients were collected from 35 institutions between 2008 and 2019. We designed a new histopathological classification of GEN-FGML using immunohistochemical analysis and analyzed via clinicopathological, immunohistochemical, and genetic evaluation. Results GEN-FGML was classified into 3 major types; oxyntic gland adenoma (OGA), GA-FG, and gastric adenocarcinoma of fundic-gland mucosa type (GA-FGM). In addition, GA-FGM was classified into 3 subtypes; Type 1 (organized with exposure type), Type 2 (disorganized with exposure type), and Type 3 (disorganized with non-exposure type). OGA and GA-FG demonstrated low-grade epithelial neoplasm, and GA-FGM should be categorized as an aggressive variant of GEN-FGML that demonstrated high-grade epithelial neoplasm (Type 2 > 1, 3). The frequent presence of GNAS mutation was a characteristic genetic feature of GEN-FGML (7/34, 20.6%; OGA 1/3, 33.3%; GA-FG 3/24, 12.5%; GA-FGM 3/7, 42.9%) in mutation analysis using next-generation sequencing. Conclusions We have established a new histopathological classification of GEN-FGML and propose a new lineage of gastric epithelial neoplasm that harbors recurrent GNAS mutation. This classification will be useful to estimate the malignant potential of GEN-FGML and establish an appropriate standard therapeutic approach.
引用
收藏
页码:814 / 828
页数:15
相关论文